CBD Kills Drug-Resistant Bacteria
This is a scientific guide.
Based on the latest medical studies.
- know how CBD and antibiotics work together against Staph and Listeria bacteria
- discover how CBD may save us from a future of drug-resistant superbugs
Let’s get started.
2020 CBD Research
CBD makes antibiotics significantly more effective against drug-resistant bacteria.
New CBD Study Published March 2020
- CBD used in combination with bacitracin (a topical antibiotic cream) resulted in a greater than 64 fold increase in the effectiveness of bacitracin against gram-positive bacteria such as Staphylococcus species, Listeria monocytogenes, and Enterococcus faecalis. All are common and potential deadly human pathogens (1).
- The addition of CBD to bacitracin had a synergistic effect which helped to more effectively kill drug-resistant bacteria strains (2).
- The findings of this study suggest that CBD is an effective “helper compound” for killing gram-positive bacteria (3).
- Because less antibiotic is needed to effectively treat infections when helper compounds like CBD are employed, the risk of developing antibiotic-resistant bacteria is decreased (4).
CBD Antibiotic Synergy:
- To determine the synergistic antibiotic effects of bacitracin (BAC) and CBD, a time-kill assay was performed to test whether or not CBD actually increased the effectiveness of bacitracin (5).
- There was no synergistic effect for CBD and bacitracin against gram-negative bacterias such as Pseudomonas aeruginosa, Salmonella typhimurium, Klebsiella pneumoniae, and Escherichia coli.
- Difficulty treating drug-resistant bacteria such as Staphylococcus aureus has sparked a search for new antibiotic compounds and treatment strategies (6).
Keywords: cannabidiol, antibiotics, antibacterial
Wassmann CS, Højrup P, Klitgaard JK. Cannabidiol is an effective helper compound in combination with bacitracin to kill Gram-positive bacteria. Sci Rep. 2020;10(1):4112. Published 2020 Mar 5. doi:10.1038/s41598-020-60952-0